<DOC>
	<DOCNO>NCT01897740</DOCNO>
	<brief_summary>The purpose study provide Sildenafil therapy subject complete A1481156 study judge investigator derive clinical benefit continue treatment Sildenafil , prior reimbursement availability subject Russian Federation .</brief_summary>
	<brief_title>Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Patients Who Completed study A1481156 Are Judged Investigator Derive Clinical Benefit Continued Treatment Sildenafil , Prior Reimbursement Availability Subjects Russian Federation . Child bear age woman apropriate contraception . Signed informed consent . Patients wish possibility follow treatment regimen term study . Pregnant lactate woman . Participation study current moment study period except A1481156 . Patients severe acute chronic disease psychiatric disorder laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>sildenafil</keyword>
	<keyword>pulmonary arterial hypertension</keyword>
	<keyword>PAH</keyword>
</DOC>